US Patent Issued to VANDERBILT UNIVERSITY on Aug. 4 for "Human antibodies to Crimean Congo Hemorrhagic Fever Virus" (Tennessee Inventor)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,699,092, issued on Aug. 4, was assigned to VANDERBILT UNIVERSITY (Nashville, Tenn.).

"Human antibodies to Crimean Congo Hemorrhagic Fever Virus" was invented by James E. Crowe Jr. (Nashville, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to antibodies binding to and neutralizing Crimean Congo Hemorrhagic Fever Virus and methods for use thereof."

The patent was filed on Jan. 11, 2021, under Application No. 17/792,008.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=5...